A prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B live cold-adapted (liquid CAIV-T) administered concomitantly with live, attended, poliovrus vaccine in healthy children

Full metadata record
DC FieldValueLanguage
dc.contributor.authorBreiman, Robert F.-
dc.contributor.authorBrooks, Abdullah-
dc.contributor.authorNaheed, Aliya-
dc.date.accessioned2008-02-05T08:14:32Z-
dc.date.available2008-02-05T08:14:32Z-
dc.date.issued2001-
dc.identifier.urihttp://hdl.handle.net/123456789/619-
dc.format.extent1996675 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoenen
dc.relation.ispartofseriesICDDRB research protocol; no. 2001-011en
dc.subjectInfluenzaen
dc.subjectInfluenzavirus A,Ben
dc.subjectInfluenza Vaccineen
dc.subjectChildrenen
dc.subjectBangladeshen
dc.titleA prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B live cold-adapted (liquid CAIV-T) administered concomitantly with live, attended, poliovrus vaccine in healthy childrenen
dc.typeArticleen
Appears in Collections:Infectious diseases and vaccine sciences research protocols

Files in This Item:
File Description SizeFormat 
ICDDRBProtocol-2001-011.pdf1.95 MBAdobe PDFView/Open


This item is protected by original copyright